Login / Signup

Despite higher revision rate, MoM large-head THA offers better clinical scores than HR: 14-year results from a randomized controlled trial involving 48 patients.

Lazaros KostretzisMartin LavigneMarc-Olivier KissMaged ShahinJanie BarryPascal-André Vendittoli
Published in: BMC musculoskeletal disorders (2021)
ClinicalTrials.gov ( NCT04516239 ), August 18, 2020. Retrospectively registered.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • total knee arthroplasty
  • prognostic factors
  • patient reported outcomes